- Investing Ideas
- /
- U.S. Strong Past Earnings Growth, P/E Ratio Below 20
U.S. Strong Past Earnings Growth, P/E Ratio Below 20
Results
135
7 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
135 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BRK.A | US$663,000.01 | -2.7% | 20.2% | US$974.4b | US$746,755.25 | PE8.9x | E-41.6% | n/a | Diversified Financials | ||
QCOM | US$156.96 | -0.5% | 12.0% | US$176.7b | US$204.70 | PE17.2x | E7.1% | 2.2% | Semiconductors | ||
CB | US$266.65 | -1.9% | 17.2% | US$107.5b | US$301.25 | PE10.8x | E2.3% | 1.4% | Insurance | ||
JD | US$33.10 | -6.3% | 34.0% | US$50.3b | US$48.65 | PE10.1x | E8.5% | 2.2% | Retail | ||
BKR | US$43.44 | 1.8% | 37.8% | US$43.0b | US$46.68 | PE19.2x | E10.4% | 1.9% | Energy | ||
CNC | US$61.83 | 0.6% | -21.5% | US$31.9b | US$78.92 | PE10.2x | E3.0% | n/a | Healthcare | ||
HIG | US$109.42 | -0.07% | 33.2% | US$31.7b | US$129.65 | PE10.5x | E7.5% | 1.9% | Insurance | ||
HPE | US$22.08 | 1.2% | 39.0% | US$29.0b | US$24.31 | PE11.4x | E0.6% | 2.4% | Tech | ||
SYF | US$65.79 | -1.5% | 79.1% | US$25.6b | US$74.31 | PE8.3x | E-5.4% | 1.5% | Diversified Financials | ||
TROW | US$108.55 | -5.4% | -1.8% | US$25.1b | US$115.86 | PE11.8x | E1.7% | 4.6% | Diversified Financials | ||
L | US$83.53 | -1.0% | 17.5% | US$18.2b | n/a | PE10.9x | n/a | 0.3% | Insurance | ||
KSPI | US$91.63 | -7.3% | -5.6% | US$18.2b | US$130.76 | PE9.4x | E23.7% | 7.0% | Diversified Financials | ||
MOH | US$286.08 | -2.9% | -24.8% | US$17.1b | US$358.46 | PE14.3x | E14.4% | n/a | Healthcare | ||
BF.B | US$33.86 | -6.6% | -39.3% | US$16.9b | US$47.58 | PE15.9x | E3.7% | 2.7% | Food, Beverage & Tobacco | ||
CSL | US$369.10 | -0.5% | 22.2% | US$16.9b | US$484.17 | PE18.7x | E6.3% | 1.1% | Capital Goods | ||
UTHR | US$364.97 | 2.4% | 66.6% | US$16.4b | US$398.02 | PE14.7x | E10.0% | n/a | Pharmaceuticals & Biotech | ||
EG | US$353.52 | -3.2% | -4.6% | US$15.8b | US$431.50 | PE5.5x | E7.3% | 2.3% | Insurance | ||
FNF New | US$54.25 | -4.5% | 8.8% | US$15.3b | US$67.80 | PE19.8x | E26.0% | 3.7% | Insurance | ||
UNM | US$71.80 | -1.8% | 58.3% | US$13.3b | US$80.36 | PE7.4x | E-3.7% | 2.3% | Insurance | ||
CNA | US$47.52 | -0.6% | 12.6% | US$12.9b | US$50.00 | PE9.9x | E15.8% | 7.9% | Insurance | ||
NVT New | US$69.85 | -1.1% | 24.2% | US$11.5b | US$84.62 | PE19.9x | E0.6% | 1.1% | Capital Goods | ||
SF | US$108.52 | 0.3% | 56.6% | US$11.1b | US$114.00 | PE18.1x | E13.4% | 1.5% | Diversified Financials | ||
AIZ | US$205.42 | -3.0% | 24.8% | US$10.5b | US$233.20 | PE14.2x | E14.3% | 1.4% | Insurance | ||
SEIC | US$79.00 | -3.5% | 24.0% | US$10.5b | US$85.60 | PE18.6x | E7.0% | 1.2% | Diversified Financials |